top of page
A-logo-of-performance-io-in-blue-and-its-tagline-redefining-search-in-white.png
PIO is a specialist provider of digital performance marketing services to the pharmaceutical industry.
PIO homepage banner.webp
Portfolio Icons__KEY DETAILS-06.png

60

Team members

Portfolio Icons__KEY DETAILS-02.png

London

Headquarters

Portfolio Icons__KEY DETAILS-01.png

Business Services

Sector

Portfolio Icons__KEY DETAILS-04.png

3

Global offices

Portfolio Icons__KEY DETAILS-05.png

May 2025

Investment date

Portfolio Icons__KEY DETAILS-03.png

Current

Status

Honeycomb background 1-01.png
Overview

PIO is a specialist performance marketing agency focused on optimising digital marketing spend for large pharma companies. Effective digital marketing strategies increase organic website traffic, as well as improving engagement with patients and healthcare professionals.

 

The organisation is led by founder and CEO Matt Lowe, and CCO Jason Brown.

PIO web analytics_edited.jpg
pio surf woman_edited.jpg
Investment strategy

Digital marketing adoption across the pharma sector is growing but remains significantly behind other industries. PIO combines deep pharma expertise with best-in-class, tech-enabled SEO services, positioning PIO as one of the few scaled specialists in the sector. Apiary will support PIO’s management team to invest in people and technology as the company scales and accelerates its expansion across the US and Asia.

Investment Team
Image for bottom of home page v2-01.png

“We are delighted to have secured the support of Apiary Capital. It was always critical to us to find an investment partner that had the right cultural fit and appreciated that the values we have as an organisation are key to our success."

Matt Lowe, founder and CEO

Apiary vertical_white-01-01.png
Apiary Capital LLP
6 Warwick Street, London W1B 5LX
+44 (0) 203 034 7600
info@apiarycapital.com
Location icon_grey.png
LinkedIn icon_grey.png

Apiary Capital LLP is incorporated as a Limited Liability Partnership in England and Wales under the partnership number OC417522 and is authorised and regulated by the Financial Conduct Authority under the reference number 790024.

bottom of page